社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
soosoo
IP属地：未知
+关注
帖子 · 128
帖子 · 128
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
soosoo
soosoo
·
2021-12-30
Good
非常抱歉，此主贴已删除
看
3,974
回复
1
点赞
5
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-29
Go to go Tesla
Why Tesla Stock Is in a ‘Clear Position of Strength’ Heading Into 2022<blockquote>为什么特斯拉股票在 2022 年处于 “明显的强势地位”</blockquote>
Tesla “is in a clear position of strength heading into 2022,” according to analysts at Wedbush, who
Why Tesla Stock Is in a ‘Clear Position of Strength’ Heading Into 2022<blockquote>为什么特斯拉股票在 2022 年处于 “明显的强势地位”</blockquote>
看
3,785
回复
评论
点赞
6
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-28
$Tesla Motors(TSLA)$
ggo go go
看
3,841
回复
2
点赞
3
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-28
Let's monitor
非常抱歉，此主贴已删除
看
3,767
回复
评论
点赞
2
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-25
Nice
非常抱歉，此主贴已删除
看
3,580
回复
2
点赞
5
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-25
Nice
非常抱歉，此主贴已删除
看
3,675
回复
评论
点赞
2
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-24
Good sharing
Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底创下新高？</blockquote>
Apple stock is higher on Thursday and could try to make a push to records before the end of the year
Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底创下新高？</blockquote>
看
4,064
回复
评论
点赞
4
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-23
Good news
非常抱歉，此主贴已删除
看
3,560
回复
评论
点赞
3
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-23
Ok
非常抱歉，此主贴已删除
看
3,646
回复
评论
点赞
3
编组 21备份 2
分享
举报
soosoo
soosoo
·
2021-12-22
Good sharing
S. Korea begins review of Pfizer's oral COVID-19 pill<blockquote>韩国开始审查辉瑞口服 COVID-19 药丸</blockquote>
SEOUL, Dec. 22 (Yonhap) -- South Korea's drug safety agency said Wednesday that it has begun reviewi
S. Korea begins review of Pfizer's oral COVID-19 pill<blockquote>韩国开始审查辉瑞口服 COVID-19 药丸</blockquote>
看
3,693
回复
1
点赞
5
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4089777453696550","uuid":"4089777453696550","gmtCreate":1626674415058,"gmtModify":1628260928452,"name":"soosoo","pinyin":"soosoo","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":20,"headSize":309,"tweetSize":128,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.04.22","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.10","exceedPercentage":"80.69%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.10","exceedPercentage":"93.94%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":692305731,"gmtCreate":1640838586413,"gmtModify":1640838586678,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/692305731","repostId":"2195466435","repostType":4,"isVote":1,"tweetType":1,"viewCount":3974,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696731485,"gmtCreate":1640765003917,"gmtModify":1640765004187,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Go to go Tesla","listText":"Go to go Tesla","text":"Go to go Tesla","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696731485","repostId":"1189803272","repostType":4,"repost":{"id":"1189803272","kind":"news","pubTimestamp":1640763988,"share":"https://www.laohunote.com/m/news/1189803272?lang=zh_CN&edition=full","pubTime":"2021-12-29 15:46","market":"us","language":"en","title":"Why Tesla Stock Is in a ‘Clear Position of Strength’ Heading Into 2022<blockquote>为什么特斯拉股票在 2022 年处于 “明显的强势地位”</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1189803272","media":"Barrons","summary":"Tesla “is in a clear position of strength heading into 2022,” according to analysts at Wedbush, who ","content":"<p><html><head></head><body>Tesla “is in a clear position of strength heading into 2022,” according to analysts at Wedbush, who see three catalysts, including China demand, driving the stock higher.</p><p><blockquote><html><head></head><body>韦德布什公司（Wedbush）的分析师认为，特斯拉 “在进入 2022 年时处于明显的强势地位”，他们认为包括中国需求在内的三个催化剂将推动该股走高。</body></html></blockquote></p><p>Wedbush has a current base price target on Tesla (ticker: TSLA) shares of $1,400 and a bull case target of $1,800. The Wedbush analysts, led by Dan Ives, wrote in a note they were maintaining their Outperform rating on the stock.</p><p><blockquote>Wedbush 目前对特斯拉（股票代码：TSLA）股票的基本目标价为 1,400 美元，牛市目标价为 1,800 美元。由丹·艾夫斯 (Dan Ives) 领导的韦德布什分析师在一份报告中写道，他们维持该股跑赢大盘的评级。</blockquote></p><p>Tesla fell 0.5% to $1,088.47 on Tuesday. The stock has gained 54.5% in 2021 and its market capitalization has moved above $1 trillion.</p><p><blockquote>特斯拉周二下跌 0.5%，至 1,088.47 美元。该股在 2021 年上涨了 54.5%，市值已超过 1 万亿美元。</blockquote></p><p>Ives said the “linchpin to the overall bull thesis on Tesla remains China,” and he estimated the country will make up 40% of deliveries for the electric-vehicle maker in 2022. He also said China was worth $400 a share to Tesla next year.</p><p><blockquote>艾夫斯说，“特斯拉整体看涨论点的关键仍然是中国”，他估计到 2022 年，中国将占这家电动汽车制造商交付量的 40%。他还表示，明年中国大陆对特斯拉来说每股价值400美元。</blockquote></p><p>The analyst said Tesla has a “high-class problem of demand outstripping supply” and said the key to alleviating these issues centered around Gigafactory openings in Austin, Texas and Berlin that will “alleviate the bottlenecks of production for Tesla globally.”</p><p><blockquote>这位分析师说，特斯拉存在 “供不应求的高级问题”，并表示缓解这些问题的关键在于奥斯丁、德克萨斯和柏林的超级工厂开业，这将 “缓解全球特斯拉的生产瓶颈”。</blockquote></p><p>“We believe by the end of 2022 Tesla will have the capacity for overall ~2 million units annually from roughly 1 million today,” Ives said.</p><p><blockquote>“艾夫斯说：”我们相信，到 2022 年底，特斯拉的年产能将从目前的约 100 万台增加到约 200 万台。</blockquote></p><p>The EV maker also should be able to smooth out supply-chain issues that have been a drag on overall unit growth for Tesla in 2021, according to Ives.</p><p><blockquote>艾夫斯表示，这家电动汽车制造商还应该能够解决阻碍特斯拉 2021 年整体单位增长的供应链问题。</blockquote></p><p>“While logistical hurdles will be a near-term cost burden, we importantly believe Tesla has the potential to further expand its auto [gross margin] and profitability profile over the next 12 to 18 months especially with more higher-margin cars being sold and produced in China,” Ives added.</p><p><blockquote>“艾夫斯补充说：”虽然物流障碍将是短期内的成本负担，但我们认为，特斯拉有潜力在未来12到18个月内进一步扩大其汽车[毛利率]和盈利能力，尤其是在中国销售和生产更多利润率较高的汽车的情况下。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Tesla Stock Is in a ‘Clear Position of Strength’ Heading Into 2022<blockquote>为什么特斯拉股票在 2022 年处于 “明显的强势地位”</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Tesla Stock Is in a ‘Clear Position of Strength’ Heading Into 2022<blockquote>为什么特斯拉股票在 2022 年处于 “明显的强势地位”</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Barrons</strong><span class=\"h-time small\">2021-12-29 15:46</span>\n</p>\n</h4>\n</header>\n<article>\n<p><html><head></head><body>Tesla “is in a clear position of strength heading into 2022,” according to analysts at Wedbush, who see three catalysts, including China demand, driving the stock higher.</p><p><blockquote><html><head></head><body>韦德布什公司（Wedbush）的分析师认为，特斯拉 “在进入 2022 年时处于明显的强势地位”，他们认为包括中国需求在内的三个催化剂将推动该股走高。</body></html></blockquote></p><p>Wedbush has a current base price target on Tesla (ticker: TSLA) shares of $1,400 and a bull case target of $1,800. The Wedbush analysts, led by Dan Ives, wrote in a note they were maintaining their Outperform rating on the stock.</p><p><blockquote>Wedbush 目前对特斯拉（股票代码：TSLA）股票的基本目标价为 1,400 美元，牛市目标价为 1,800 美元。由丹·艾夫斯 (Dan Ives) 领导的韦德布什分析师在一份报告中写道，他们维持该股跑赢大盘的评级。</blockquote></p><p>Tesla fell 0.5% to $1,088.47 on Tuesday. The stock has gained 54.5% in 2021 and its market capitalization has moved above $1 trillion.</p><p><blockquote>特斯拉周二下跌 0.5%，至 1,088.47 美元。该股在 2021 年上涨了 54.5%，市值已超过 1 万亿美元。</blockquote></p><p>Ives said the “linchpin to the overall bull thesis on Tesla remains China,” and he estimated the country will make up 40% of deliveries for the electric-vehicle maker in 2022. He also said China was worth $400 a share to Tesla next year.</p><p><blockquote>艾夫斯说，“特斯拉整体看涨论点的关键仍然是中国”，他估计到 2022 年，中国将占这家电动汽车制造商交付量的 40%。他还表示，明年中国大陆对特斯拉来说每股价值400美元。</blockquote></p><p>The analyst said Tesla has a “high-class problem of demand outstripping supply” and said the key to alleviating these issues centered around Gigafactory openings in Austin, Texas and Berlin that will “alleviate the bottlenecks of production for Tesla globally.”</p><p><blockquote>这位分析师说，特斯拉存在 “供不应求的高级问题”，并表示缓解这些问题的关键在于奥斯丁、德克萨斯和柏林的超级工厂开业，这将 “缓解全球特斯拉的生产瓶颈”。</blockquote></p><p>“We believe by the end of 2022 Tesla will have the capacity for overall ~2 million units annually from roughly 1 million today,” Ives said.</p><p><blockquote>“艾夫斯说：”我们相信，到 2022 年底，特斯拉的年产能将从目前的约 100 万台增加到约 200 万台。</blockquote></p><p>The EV maker also should be able to smooth out supply-chain issues that have been a drag on overall unit growth for Tesla in 2021, according to Ives.</p><p><blockquote>艾夫斯表示，这家电动汽车制造商还应该能够解决阻碍特斯拉 2021 年整体单位增长的供应链问题。</blockquote></p><p>“While logistical hurdles will be a near-term cost burden, we importantly believe Tesla has the potential to further expand its auto [gross margin] and profitability profile over the next 12 to 18 months especially with more higher-margin cars being sold and produced in China,” Ives added.</p><p><blockquote>“艾夫斯补充说：”虽然物流障碍将是短期内的成本负担，但我们认为，特斯拉有潜力在未来12到18个月内进一步扩大其汽车[毛利率]和盈利能力，尤其是在中国销售和生产更多利润率较高的汽车的情况下。</blockquote></p><p></body></html></p><p><blockquote></blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.barrons.com/articles/tesla-stock-price-2022-catalysts-51640686538?mod=hp_LATEST\">Barrons</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.barrons.com/articles/tesla-stock-price-2022-catalysts-51640686538?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1189803272","content_text":"Tesla “is in a clear position of strength heading into 2022,” according to analysts at Wedbush, who see three catalysts, including China demand, driving the stock higher.Wedbush has a current base price target on Tesla (ticker: TSLA) shares of $1,400 and a bull case target of $1,800. The Wedbush analysts, led by Dan Ives, wrote in a note they were maintaining their Outperform rating on the stock.Tesla fell 0.5% to $1,088.47 on Tuesday. The stock has gained 54.5% in 2021 and its market capitalization has moved above $1 trillion.Ives said the “linchpin to the overall bull thesis on Tesla remains China,” and he estimated the country will make up 40% of deliveries for the electric-vehicle maker in 2022. He also said China was worth $400 a share to Tesla next year.The analyst said Tesla has a “high-class problem of demand outstripping supply” and said the key to alleviating these issues centered around Gigafactory openings in Austin, Texas and Berlin that will “alleviate the bottlenecks of production for Tesla globally.”“We believe by the end of 2022 Tesla will have the capacity for overall ~2 million units annually from roughly 1 million today,” Ives said.The EV maker also should be able to smooth out supply-chain issues that have been a drag on overall unit growth for Tesla in 2021, according to Ives.“While logistical hurdles will be a near-term cost burden, we importantly believe Tesla has the potential to further expand its auto [gross margin] and profitability profile over the next 12 to 18 months especially with more higher-margin cars being sold and produced in China,” Ives added.","news_type":1,"symbols_score_info":{"TSLA":0.9}},"isVote":1,"tweetType":1,"viewCount":3785,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696614274,"gmtCreate":1640681609445,"gmtModify":1640681610383,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>ggo go go","listText":"<a href=\"https://laohu8.com/S/TSLA\">$Tesla Motors(TSLA)$</a>ggo go go","text":"$Tesla Motors(TSLA)$ggo go go","images":[{"img":"https://static.tigerbbs.com/5e5f2ba77b3aa9f59dbbd7bb7c2ef534","width":"1080","height":"1920"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/696614274","isVote":1,"tweetType":1,"viewCount":3841,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0},{"id":696827745,"gmtCreate":1640667773310,"gmtModify":1640667929137,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Let's monitor","listText":"Let's monitor","text":"Let's monitor","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696827745","repostId":"2194047961","repostType":4,"isVote":1,"tweetType":1,"viewCount":3767,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698507088,"gmtCreate":1640433504559,"gmtModify":1640433504793,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/698507088","repostId":"1156159690","repostType":4,"isVote":1,"tweetType":1,"viewCount":3580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698504741,"gmtCreate":1640433495201,"gmtModify":1640433495436,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698504741","repostId":"1156159690","repostType":4,"isVote":1,"tweetType":1,"viewCount":3675,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698374604,"gmtCreate":1640311998373,"gmtModify":1640313512460,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Good sharing","listText":"Good sharing","text":"Good sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698374604","repostId":"1168865278","repostType":4,"repost":{"id":"1168865278","kind":"news","pubTimestamp":1640311666,"share":"https://www.laohunote.com/m/news/1168865278?lang=zh_CN&edition=full","pubTime":"2021-12-24 10:07","market":"us","language":"en","title":"Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底创下新高？</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1168865278","media":"TheStreet","summary":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year","content":"<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.</p><p><blockquote>苹果股价周四走高，并可能试图在年底前创下历史新高。</blockquote></p><p> Apple shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.</p><p><blockquote>本月早些时候，苹果股价是市场领头羊，但在过去几个交易日中，它们一直在波动。</blockquote></p><p> As the overall market continued to sway with volatility, Apple was a beacon of strength. We were lucky with Apple stock. In fact, incredibly lucky.</p><p><blockquote>由于整体市场继续波动，苹果是力量的灯塔。我们很幸运有苹果股票。事实上，非常幸运。</blockquote></p><p> On Dec. 13 the Cupertino, Calif., tech giant was approaching a $3 trillion valuation. But I wrote about the potential sell-the-news bearish reversal that was in play. The stock then posted five daily losses in a six-session span.</p><p><blockquote>12月13日，这家总部位于加州库比蒂诺的科技巨头的估值接近3万亿美元。但我写了关于潜在的卖出新闻的看跌反转。随后，该股在六个交易日内出现了五次每日下跌。</blockquote></p><p> Apple has now begun to find its footing.</p><p><blockquote>苹果现在已经开始找到自己的立足点。</blockquote></p><p> It was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&P 500.</p><p><blockquote>最近有报道称，苹果上个季度大量购买了自己的股票——考虑到其回购承诺，这并不奇怪——因为它引领了标普500。</blockquote></p><p> Now bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.</p><p><blockquote>现在多头想知道所有这些购买最终是否会得到回报。让我们来看看图表。</blockquote></p><p> <b>Trading Apple Stock</b></p><p><blockquote><b>交易苹果股票</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6865ca6e0def05bb2a060b2af13be892\" tg-width=\"1139\" tg-height=\"866\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p><p><blockquote><p class=\"t-img-caption\"><span>苹果股票日线图。</span></p></blockquote></p><p> This morning I had Apple on my radar. Why? It’s simple.</p><p><blockquote>今天早上我盯上了苹果。为什么？很简单。</blockquote></p><p> Look at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.</p><p><blockquote>看看苹果股价周五和周一收盘走低，但两次开盘后都上涨。我们从蜡烛的外观就知道了。</blockquote></p><p> Rather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.</p><p><blockquote>我们有两根空心红色蜡烛，而不是填充的深红色蜡烛（像12月16日星期四）。这表明开盘时收盘价较高，尽管该股当天收盘走低。换句话说，多头在开盘低点买入。</blockquote></p><p> Further, Apple stock was holding the 21-day moving average.</p><p><blockquote>此外，苹果股价持有 21 日移动平均线。</blockquote></p><p> With yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.</p><p><blockquote>随着昨天的反弹，苹果不仅在 21 日移动平均线上方反弹，而且收于 10 日移动平均线之上。</blockquote></p><p> That had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.</p><p><blockquote>这使得交易员们希望在周二高点 173.20 美元的基础上进行每日上涨轮动。</blockquote></p><p> From here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.</p><p><blockquote>从这里我想看看苹果股票能否继续走高。它高于所有主要的每日移动平均线。</blockquote></p><p> If it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.</p><p><blockquote>如果价格继续走高，下降趋势阻力和 179.50 美元区域就会发挥作用。苹果两次未能突破 180 美元。因此，如果它确实走高，我们希望认识到这个区域。</blockquote></p><p> Above $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple finds a few upside extensions.</p><p><blockquote>超过 180 美元将打开历史高点 182.13 美元的大门。除此之外，我们可以开始讨论 188 美元至 194 美元的区域，苹果在该区域发现了一些上行扩展。</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Can Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底创下新高？</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCan Apple Stock Hit New Highs by Year's End?<blockquote>苹果股价能否在年底创下新高？</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">TheStreet</strong><span class=\"h-time small\">2021-12-24 10:07</span>\n</p>\n</h4>\n</header>\n<article>\n<p>Apple stock is higher on Thursday and could try to make a push to records before the end of the year.</p><p><blockquote>苹果股价周四走高，并可能试图在年底前创下历史新高。</blockquote></p><p> Apple shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.</p><p><blockquote>本月早些时候，苹果股价是市场领头羊，但在过去几个交易日中，它们一直在波动。</blockquote></p><p> As the overall market continued to sway with volatility, Apple was a beacon of strength. We were lucky with Apple stock. In fact, incredibly lucky.</p><p><blockquote>由于整体市场继续波动，苹果是力量的灯塔。我们很幸运有苹果股票。事实上，非常幸运。</blockquote></p><p> On Dec. 13 the Cupertino, Calif., tech giant was approaching a $3 trillion valuation. But I wrote about the potential sell-the-news bearish reversal that was in play. The stock then posted five daily losses in a six-session span.</p><p><blockquote>12月13日，这家总部位于加州库比蒂诺的科技巨头的估值接近3万亿美元。但我写了关于潜在的卖出新闻的看跌反转。随后，该股在六个交易日内出现了五次每日下跌。</blockquote></p><p> Apple has now begun to find its footing.</p><p><blockquote>苹果现在已经开始找到自己的立足点。</blockquote></p><p> It was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&P 500.</p><p><blockquote>最近有报道称，苹果上个季度大量购买了自己的股票——考虑到其回购承诺，这并不奇怪——因为它引领了标普500。</blockquote></p><p> Now bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.</p><p><blockquote>现在多头想知道所有这些购买最终是否会得到回报。让我们来看看图表。</blockquote></p><p> <b>Trading Apple Stock</b></p><p><blockquote><b>交易苹果股票</b></blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/6865ca6e0def05bb2a060b2af13be892\" tg-width=\"1139\" tg-height=\"866\" width=\"100%\" height=\"auto\"><span>Daily chart of Apple stock.</span></p><p><blockquote><p class=\"t-img-caption\"><span>苹果股票日线图。</span></p></blockquote></p><p> This morning I had Apple on my radar. Why? It’s simple.</p><p><blockquote>今天早上我盯上了苹果。为什么？很简单。</blockquote></p><p> Look at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.</p><p><blockquote>看看苹果股价周五和周一收盘走低，但两次开盘后都上涨。我们从蜡烛的外观就知道了。</blockquote></p><p> Rather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.</p><p><blockquote>我们有两根空心红色蜡烛，而不是填充的深红色蜡烛（像12月16日星期四）。这表明开盘时收盘价较高，尽管该股当天收盘走低。换句话说，多头在开盘低点买入。</blockquote></p><p> Further, Apple stock was holding the 21-day moving average.</p><p><blockquote>此外，苹果股价持有 21 日移动平均线。</blockquote></p><p> With yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.</p><p><blockquote>随着昨天的反弹，苹果不仅在 21 日移动平均线上方反弹，而且收于 10 日移动平均线之上。</blockquote></p><p> That had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.</p><p><blockquote>这使得交易员们希望在周二高点 173.20 美元的基础上进行每日上涨轮动。</blockquote></p><p> From here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.</p><p><blockquote>从这里我想看看苹果股票能否继续走高。它高于所有主要的每日移动平均线。</blockquote></p><p> If it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.</p><p><blockquote>如果价格继续走高，下降趋势阻力和 179.50 美元区域就会发挥作用。苹果两次未能突破 180 美元。因此，如果它确实走高，我们希望认识到这个区域。</blockquote></p><p> Above $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple finds a few upside extensions.</p><p><blockquote>超过 180 美元将打开历史高点 182.13 美元的大门。除此之外，我们可以开始讨论 188 美元至 194 美元的区域，苹果在该区域发现了一些上行扩展。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021\">TheStreet</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/investing/trading-apple-aapl-stock-new-highs-before-year-end-december-2021","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168865278","content_text":"Apple stock is higher on Thursday and could try to make a push to records before the end of the year.\nApple shares earlier this month were a market leader, but over the past few trading sessions, they've wobbled.\nAs the overall market continued to sway with volatility, Apple was a beacon of strength. We were lucky with Apple stock. In fact, incredibly lucky.\nOn Dec. 13 the Cupertino, Calif., tech giant was approaching a $3 trillion valuation. But I wrote about the potential sell-the-news bearish reversal that was in play. The stock then posted five daily losses in a six-session span.\nApple has now begun to find its footing.\nIt was recently reported that Apple was a massive buyer of its own stock last quarter — which is no surprise given its buyback commitment —as it led the S&P 500.\nNow bulls are wondering if all that buying will eventually pay off. Let’s look at the charts.\nTrading Apple Stock\nDaily chart of Apple stock.\nThis morning I had Apple on my radar. Why? It’s simple.\nLook at the way shares of Apple closed lower on Friday and Monday, but both times rallied from the open. We know that by the look of the candle.\nRather than a filled-in, deep-red candle (like Thursday, Dec. 16), we have two hollow red candles. That shows us a higher close from the open, even though the stock ended lower on the day. In other words, bulls were buying the opening dips.\nFurther, Apple stock was holding the 21-day moving average.\nWith yesterday’s bounce, Apple not only rallied off the 21-day moving average, it closed above the 10-day moving average.\nThat had traders looking for a daily-up rotation over Tuesday’s high, at $173.20.\nFrom here I want to see whether Apple stock can continue to push higher. It’s above all its major daily moving averages.\nIf it does continue higher, downtrend resistance and the $179.50 area are in play. Twice, Apple has failed on its push over $180. So if it does make a run higher, we want to be cognizant of this zone.\nAbove $180 opens the door to the all-time high, at $182.13. Above that and we can start talking about the $188 to $194 zone, where Apple finds a few upside extensions.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":4064,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691241327,"gmtCreate":1640215606821,"gmtModify":1640215612910,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Good news","listText":"Good news","text":"Good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691241327","repostId":"1131862374","repostType":4,"isVote":1,"tweetType":1,"viewCount":3560,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691243185,"gmtCreate":1640215559853,"gmtModify":1640215560119,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691243185","repostId":"1158266085","repostType":4,"isVote":1,"tweetType":1,"viewCount":3646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691125672,"gmtCreate":1640153102058,"gmtModify":1640153102425,"author":{"id":"4089777453696550","authorId":"4089777453696550","name":"soosoo","avatar":"https://static.tigerbbs.com/a7a8e4a0c1e8d4b7bf1e9db91cfaffc8","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4089777453696550","idStr":"4089777453696550"},"themes":[],"title":"","htmlText":"Good sharing","listText":"Good sharing","text":"Good sharing","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691125672","repostId":"1188384720","repostType":4,"repost":{"id":"1188384720","kind":"news","pubTimestamp":1640152952,"share":"https://www.laohunote.com/m/news/1188384720?lang=zh_CN&edition=full","pubTime":"2021-12-22 14:02","market":"us","language":"en","title":"S. Korea begins review of Pfizer's oral COVID-19 pill<blockquote>韩国开始审查辉瑞口服 COVID-19 药丸</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1188384720","media":"Yonhap","summary":"SEOUL, Dec. 22 (Yonhap) -- South Korea's drug safety agency said Wednesday that it has begun reviewi","content":"<p>SEOUL, Dec. 22 (Yonhap) -- South Korea's drug safety agency said Wednesday that it has begun reviewing an emergency authorization of U.S. drug giant Pfizer Inc.'s oral drug to treat COVID-19.</p><p><blockquote>韩联社首尔12月22日电韩国药品安全局周三表示，已开始审查美国制药巨头辉瑞公司治疗新冠肺炎的口服药物的紧急授权。</blockquote></p><p> Paxlovid is the antiviral pill for the treatment of mild to moderate COVID-19 in patients at increased risk of hospitalization or death, according to Pfizer and the Ministry of Food and Drug Safety.</p><p><blockquote>根据辉瑞公司和食品药品安全部的说法，Paxlovid是一种抗病毒药物，用于治疗住院或死亡风险增加的患者的轻度至中度新冠肺炎。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f5435876a060de363e87a33887064854\" tg-width=\"500\" tg-height=\"324\" width=\"100%\" height=\"auto\"><span>The Ministry of Food and Drug Safety (PHOTO NOT FOR SALE) (Yonhap)</span></p><p><blockquote><p class=\"t-img-caption\"><span>食品药品安全部（照片非卖品）（韩联社）</span></p></blockquote></p><p> If authorized, Paxlovid would be the first oral antiviral of its kind in South Korea.</p><p><blockquote>如果获得批准，Paxlovid将成为韩国第一个口服抗病毒药物。</blockquote></p><p> The drug candidate is a protease inhibitor antiviral therapy that is specifically designed to be administered orally so that it can be prescribed at the first sign of infection or at first awareness of an exposure.</p><p><blockquote>候选药物是一种蛋白酶抑制剂抗病毒疗法，其专门设计为口服给药，以便在感染的第一个迹象或首次意识到暴露时可以开出处方。</blockquote></p><p> The U.S. Food and Drug Administration is poised to grant an Emergency Use Authorization approval of Paxlovid along with Merck & Co.'s pill this week, according to multiple media reports.</p><p><blockquote>美国据多家媒体报道，美国食品和药物管理局准备在本周批准 Paxlovid 和默克公司的药丸的紧急使用授权。</blockquote></p><p> Pfizer said its trial results showed Paxlovid reduces by 89 percent the risk of hospitalization or death in patients at high risk of severe illness within three days of the onset of COVID-19 symptoms.</p><p><blockquote>辉瑞公司表示，其试验结果显示，在出现 COVID-19 症状后三天内，Paxlovid 可将重症高风险患者住院或死亡的风险降低 89%。</blockquote></p><p></p>","source":"lsy1640152899971","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S. Korea begins review of Pfizer's oral COVID-19 pill<blockquote>韩国开始审查辉瑞口服 COVID-19 药丸</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS. Korea begins review of Pfizer's oral COVID-19 pill<blockquote>韩国开始审查辉瑞口服 COVID-19 药丸</blockquote>\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">Yonhap</strong><span class=\"h-time small\">2021-12-22 14:02</span>\n</p>\n</h4>\n</header>\n<article>\n<p>SEOUL, Dec. 22 (Yonhap) -- South Korea's drug safety agency said Wednesday that it has begun reviewing an emergency authorization of U.S. drug giant Pfizer Inc.'s oral drug to treat COVID-19.</p><p><blockquote>韩联社首尔12月22日电韩国药品安全局周三表示，已开始审查美国制药巨头辉瑞公司治疗新冠肺炎的口服药物的紧急授权。</blockquote></p><p> Paxlovid is the antiviral pill for the treatment of mild to moderate COVID-19 in patients at increased risk of hospitalization or death, according to Pfizer and the Ministry of Food and Drug Safety.</p><p><blockquote>根据辉瑞公司和食品药品安全部的说法，Paxlovid是一种抗病毒药物，用于治疗住院或死亡风险增加的患者的轻度至中度新冠肺炎。</blockquote></p><p> <p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f5435876a060de363e87a33887064854\" tg-width=\"500\" tg-height=\"324\" width=\"100%\" height=\"auto\"><span>The Ministry of Food and Drug Safety (PHOTO NOT FOR SALE) (Yonhap)</span></p><p><blockquote><p class=\"t-img-caption\"><span>食品药品安全部（照片非卖品）（韩联社）</span></p></blockquote></p><p> If authorized, Paxlovid would be the first oral antiviral of its kind in South Korea.</p><p><blockquote>如果获得批准，Paxlovid将成为韩国第一个口服抗病毒药物。</blockquote></p><p> The drug candidate is a protease inhibitor antiviral therapy that is specifically designed to be administered orally so that it can be prescribed at the first sign of infection or at first awareness of an exposure.</p><p><blockquote>候选药物是一种蛋白酶抑制剂抗病毒疗法，其专门设计为口服给药，以便在感染的第一个迹象或首次意识到暴露时可以开出处方。</blockquote></p><p> The U.S. Food and Drug Administration is poised to grant an Emergency Use Authorization approval of Paxlovid along with Merck & Co.'s pill this week, according to multiple media reports.</p><p><blockquote>美国据多家媒体报道，美国食品和药物管理局准备在本周批准 Paxlovid 和默克公司的药丸的紧急使用授权。</blockquote></p><p> Pfizer said its trial results showed Paxlovid reduces by 89 percent the risk of hospitalization or death in patients at high risk of severe illness within three days of the onset of COVID-19 symptoms.</p><p><blockquote>辉瑞公司表示，其试验结果显示，在出现 COVID-19 症状后三天内，Paxlovid 可将重症高风险患者住院或死亡的风险降低 89%。</blockquote></p><p></p>\n<div class=\"bt-text\">\n\n\n<p> 来源：<a href=\"https://en.yna.co.kr/view/AEN20211222004300320?section=search\">Yonhap</a></p>\n<p>为提升您的阅读体验，我们对本页面进行了排版优化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"https://en.yna.co.kr/view/AEN20211222004300320?section=search","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188384720","content_text":"SEOUL, Dec. 22 (Yonhap) -- South Korea's drug safety agency said Wednesday that it has begun reviewing an emergency authorization of U.S. drug giant Pfizer Inc.'s oral drug to treat COVID-19.\nPaxlovid is the antiviral pill for the treatment of mild to moderate COVID-19 in patients at increased risk of hospitalization or death, according to Pfizer and the Ministry of Food and Drug Safety.\nThe Ministry of Food and Drug Safety (PHOTO NOT FOR SALE) (Yonhap)\nIf authorized, Paxlovid would be the first oral antiviral of its kind in South Korea.\nThe drug candidate is a protease inhibitor antiviral therapy that is specifically designed to be administered orally so that it can be prescribed at the first sign of infection or at first awareness of an exposure.\nThe U.S. Food and Drug Administration is poised to grant an Emergency Use Authorization approval of Paxlovid along with Merck & Co.'s pill this week, according to multiple media reports.\nPfizer said its trial results showed Paxlovid reduces by 89 percent the risk of hospitalization or death in patients at high risk of severe illness within three days of the onset of COVID-19 symptoms.","news_type":1,"symbols_score_info":{"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":3693,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}